These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29497351)

  • 21. Communication Between Epithelial-Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression.
    Zheng X; Dai F; Feng L; Zou H; Feng L; Xu M
    Front Oncol; 2021; 11():617597. PubMed ID: 33968721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis.
    Jolly MK; Boareto M; Huang B; Jia D; Lu M; Ben-Jacob E; Onuchic JN; Levine H
    Front Oncol; 2015; 5():155. PubMed ID: 26258068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
    Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
    Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial EMT in head and neck cancer biology: a spectrum instead of a switch.
    Pal A; Barrett TF; Paolini R; Parikh A; Puram SV
    Oncogene; 2021 Aug; 40(32):5049-5065. PubMed ID: 34239045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KLF4 Induces Mesenchymal-Epithelial Transition (MET) by Suppressing Multiple EMT-Inducing Transcription Factors.
    Subbalakshmi AR; Sahoo S; McMullen I; Saxena AN; Venugopal SK; Somarelli JA; Jolly MK
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC.
    Konen JM; Rodriguez BL; Padhye A; Ochieng JK; Gibson L; Diao L; Fowlkes NW; Fradette JJ; Peng DH; Cardnell RJ; Kovacs JJ; Wang J; Byers LA; Gibbons DL
    Cancer Res; 2021 Mar; 81(5):1398-1412. PubMed ID: 33402388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A data-assimilation approach to predict population dynamics during epithelial-mesenchymal transition.
    Mendez MJ; Hoffman MJ; Cherry EM; Lemmon CA; Weinberg SH
    Biophys J; 2022 Aug; 121(16):3061-3080. PubMed ID: 35836379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative RNA degradation stabilizes intermediate epithelial-mesenchymal states and supports a phenotypic continuum.
    Nordick B; Chae-Yeon Park M; Quaranta V; Hong T
    iScience; 2022 Oct; 25(10):105224. PubMed ID: 36248730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of intercellular connectivity on epithelial mesenchymal transition plasticity.
    Mandal M; Ghosh B; Rajput M; Chatterjee J
    Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118784. PubMed ID: 32590027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition.
    Subbalakshmi AR; Sahoo S; Manjunatha P; Goyal S; Kasiviswanathan VA; Mahesh Y; Ramu S; McMullen I; Somarelli JA; Jolly MK
    J Biol Eng; 2023 Mar; 17(1):17. PubMed ID: 36864480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological State Transition Dynamics in EGF-Induced Epithelial to Mesenchymal Transition.
    Devaraj V; Bose B
    J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31247884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
    Brown MS; Abdollahi B; Wilkins OM; Lu H; Chakraborty P; Ognjenovic NB; Muller KE; Jolly MK; Christensen BC; Hassanpour S; Pattabiraman DR
    Sci Adv; 2022 Aug; 8(31):eabj8002. PubMed ID: 35921406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying the landscape and kinetic paths for epithelial-mesenchymal transition from a core circuit.
    Li C; Hong T; Nie Q
    Phys Chem Chem Phys; 2016 Jul; 18(27):17949-56. PubMed ID: 27328302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Landscape and kinetic path quantify critical transitions in epithelial-mesenchymal transition.
    Lang J; Nie Q; Li C
    Biophys J; 2021 Oct; 120(20):4484-4500. PubMed ID: 34480928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
    Jayachandran A; Dhungel B; Steel JC
    J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of mesenchymal-epithelial transition in endometrial function.
    Owusu-Akyaw A; Krishnamoorthy K; Goldsmith LT; Morelli SS
    Hum Reprod Update; 2019 Jan; 25(1):114-133. PubMed ID: 30407544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis.
    Pillai M; Rajaram G; Thakur P; Agarwal N; Muralidharan S; Ray A; Barbhaya D; Somarelli JA; Jolly MK
    Front Oncol; 2022; 12():913803. PubMed ID: 36003764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data- and theory-driven approaches for understanding paths of epithelial-mesenchymal transition.
    Hong T; Xing J
    Genesis; 2024 Apr; 62(2):e23591. PubMed ID: 38553870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
    Micalizzi DS; Farabaugh SM; Ford HL
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial-to-Mesenchymal Plasticity Harnesses Endocytic Circuitries.
    Corallino S; Malabarba MG; Zobel M; Di Fiore PP; Scita G
    Front Oncol; 2015; 5():45. PubMed ID: 25767773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.